UG Healthcare says Omicron still in its early days, company to monitor situation
GLOVEMAKERS are now back in the spotlight, thanks to the Omicron coronavirus variant, which has sparked hopes of renewed demand and stronger average selling prices (ASPs) for gloves.
Lee Jun Yih, executive director of UG Healthcare, is not prepared to speculate about the impact the new variant will have on the company’s business though, saying that it is “still early days”.
In a recent interview with The Business Times, he said UG Healthcare is still monitoring the situation, and is unable to say for sure what the impact of the Omicron variant will be on demand, ASPs and profits.
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
S&P slashes Boeing credit outlook as rating hovers above junk status
Honda to spend US$11 billion on EV strategy in Canada
GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology
Mapletree Industrial Trust Q4 DPU rises 0.9% to S$0.0336
Nasdaq’s profit falls as shaky economy keeps IPO revival elusive
iFast Q1 net profit surges on ePension unit performance